Serotonin transporter gene polymorphisms and depressive symptoms in patients with chronic obstructive pulmonary disease

References

• Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010;25(12):1209–1221.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Müllerová H, Hanania NA, et al. Long-term course of depression trajectories in patients with COPD: a 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016;149(4):916–926.
   PubMed Web of Science ®Google Scholar
• Yohannes AM. Management of depression and anxiety in patients with COPD. Expert Rev Respir Med. 2008;2(3):337–347.
   PubMedGoogle Scholar
• Dierker LC, Avenevoli S, Stolar M, et al. Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry. 2002;159:947–953.
   PubMed Web of Science ®Google Scholar
• Hu S, Brody CL, Fisher C, et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry. 2000;5(2):181–188.
   PubMed Web of Science ®Google Scholar
• Pizzo de Castro MR, Vargas Nunes SO, Guembarovski RL, et al. STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders. J Affect Disord. 2015;172:347–354.
   PubMed Web of Science ®Google Scholar
• Sharpley CF, Palanisamy SKA, Glyde NS, et al. An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings. Behav Brain Res. 2014;273:89–105.
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386–389.
   PubMed Web of Science ®Google Scholar
• Fanelli G, Serretti A. The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behaviors: a meta-analysis. Prog Neuro Psychopharmacol Biol Psychiatry. 2019;88:375–387.
   PubMed Web of Science ®Google Scholar
• Bozina N, Mihaljević-Peles A, Sagud M, et al. Serotonin transporter polymorphism in croatian patients with major depressive disorder. Psychiatr Danub. 2006;18(1–2):83–89.
   PubMedGoogle Scholar
• Kao WT, Chang CL, Lung FW. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in clinical trial. J Affect Disord. 2018;238:597–608.
   PubMed Web of Science ®Google Scholar
• MacLean MR. The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 grover conference series). Pulm Circ. 2018;8(2):1–9.
   Web of Science ®Google Scholar
• Jiao Y-R, Wang W, Lei P-C, et al. 5-HTT, BMPR2, EDN1, ENG, KCNA5gene polymorphisms and susceptibility to pulmonary arterial hypertension: a meta-analysis. Gene. 2019;680:34–42.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–194.
   PubMed Web of Science ®Google Scholar
• Ulrich S, Hersberger M, Fischler M, et al. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration. 2010;79(4):288–295.
   PubMed Web of Science ®Google Scholar
• Jarrett ME, Kohen R, Cain KC, et al. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs. 2007;9(2):161–169.
   PubMed Web of Science ®Google Scholar
• Kohen R, Cain KC, Mitchell PH, et al. Association of serotonin transporter gene polymorphisms with post-stroke depression. Arch Gen Psychiatry. 2008;65(11):1296–1302.
   PubMed Web of Science ®Google Scholar
• Schure MB, Borson S, Nguyen HQ, et al. Associations of cognition with physical functioning and health-related quality of life among COPD patients. Respir Med. 2016;114:46–52.
   PubMed Web of Science ®Google Scholar
• Nguyen HQ, Herting JR, Pike KC, et al. Symptom profiles and inflammatory markers in moderate to severe COPD. BMC Pulm Med. 2016;16(1):173.
   PubMedGoogle Scholar
• Kronke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Spitzeer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID). I: history, rationale and description. Arch Gen Psychiatry. 1992;49(8):624–629.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients w ith chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
   PubMed Web of Science ®Google Scholar
• Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. Chest. 1998;113:619–624.
   PubMed Web of Science ®Google Scholar
• ATS statement: guideline for six-minute walk test. The official of American Thoracic Society was approved by the ATS board for directors, March 2002. Am J Respir Crit Care Med. 2002;166:111–117.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Cameron AC, Trivedi PK. Regression analysis of count data. 2nd ed. New York: Cambridge University Press; 2013.
   Google Scholar
• Contresaerasa J, Harea L, Camarenae B, et al. The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr Scand. 2009;119(2):117–127.
   PubMed Web of Science ®Google Scholar
• Gao Z, Yuan H, Sun M, et al. The association of serotonin transporter gene polymorphism and geriatric depression: a meta-analysis. Neurosci Lett. 2014;578:148–152.
   PubMed Web of Science ®Google Scholar
• Omari-Asor L, Stewart R, Artero S, et al. 5-HTTLPR genotype, asthma, diabetes and late life depression in an older French population. Int J Geriatr Psychiatry. 2015;30:1017–1022.
   PubMed Web of Science ®Google Scholar
• Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959–985.
   PubMed Web of Science ®Google Scholar
• Ulasli SS, Eyuboglu FO, Verdi H, et al. Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients. Mol Biol Rep. 2013;40(10):5625–5633.
   PubMed Web of Science ®Google Scholar
• Baloira A, Munez M, Cifrian J, et al. Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension. Arch Bronconeupumol. 2012;48:77–80.
   PubMed Web of Science ®Google Scholar
• Willgoss T, Yohannes AM, Goldbart J, et al. COPD and anxiety: its impact on patients lives. Nurs Times. 2011;107(15–16):523–525.
   Google Scholar
• Yohannes AM, Newman M, Kunik ME. Psychiatric collaborative care for patients with respiratory disease. Chest. 2019;155(6):1288–1295.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol. 2000;10(2):193–202.
   Google Scholar
• Goldbart J, Yohannes AM, Woolrych R, et al. ‘It is not going to change his life but it has picked him up’: a qualitative study of perspectives on long term oxygen therapy for people with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11:124.
   PubMed Web of Science ®Google Scholar
• Uchmanowicz I, Jankowska-Polanska B, Motowidlo U, et al. Assessment of illness acceptance by patients with COPD and the prevalence of depression and anxiety in COPD. Int J COPD. 2016;11:963–970.
   Google Scholar